CD8A and colorectal cancer: Pagès et al37 further demonstrated that the combined analysis of CD8+ plus CD45RO+ cells in the center of the tumor and invasive margin could provide a useful criterion for the prediction of tumor recurrence and survival in patients with early‐stage colorectal cancer.